Association of MMP9 gene - 1562 C/T polymorphism with myocardial infarction in Uighur population of Xinjiang

Chinese Journal of Medical Genetics

Volumn 28, Issue 2, 2011, Pages 180-184

  Wang, Lei ^a   Ma, Yi Tong ^a   Xie, Xiang ^a   Yang, Yi Ning ^a   Fu, Zhen Yan ^a   Liu, Fen ^a   Li, Xiao Mei ^a   Chen, Bang Dang ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Genetic polymorphism; Matrix metalloproteinase 9; Myocardial infarction; Uighur population

Indexed keywords

GELATINASE B;

ANGIOCARDIOGRAPHY; ARTICLE; CHINA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79955866779     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2011.02.013     Document Type: Article

References (19)

1. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimai thickening and atherosclerotic plaque rupture. Physiol Rev, 2005,85:1-31. (Pubitemid 40171256)
2. Cipollone F, Prontera C, Pini B, et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E (2)-dependent plaque instability. Circulation, 2001,104:921-927.
3. Cipollone F, Fazia M, Iezzi A, et al. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation, 2003,107:1479-1485. (Pubitemid 36378484)
4. Loftus IM, Naylor AR, Goodall S, et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaque. A potential role in acute plaque disruption. Stroke, 2000,31:40-47.
5. Funayama H, Ishikawa SE, Kubo N, et al. Increases in interleukin-6 and matrix metalloproteinases-9 in the infarct-related coronary artery of acute myocardial infarction. Circ J, 2004,68:451-454. (Pubitemid 38657534)
6. Morgan AR, Zhang B, Tapper W, et al. Haplotypic analysis of the MMP9 gene in relation to coronary artery disease. J Mol Med, 2003,81:321-326.
7. Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation, 1999,99:1788-1794. (Pubitemid 29181405)
8. Haberbosch W, Gardemann A. Gelatinase B C(-1562) T polymorphism in relation to ischaemic heart disease. Scand J Clin Lab Invest, 2003,63:513-522.
9. Wang J, Warzecha D, Wilcken D, et al. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis. Clin Sci (Lond), 2001,101:87-92. (Pubitemid 32634742)
10. Tang LJ, Chen XF, Zhu M, et al. Study of relations between matrix metalloproteinase-9 polymorphism (C - 1562T) and acute coronary syndrome in Han population of China. Chin J Med Genet, 2005,22:313-316. (Pubitemid 40835531)
11. Lemaitre V, D'Armiento J. Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today, 2006,78:1-10
12. Zhang X, Christenson LK, Nothnick WB. Regulation of MMPy expression and activity in the mouse uterus by estrogen. Mol Reprod Dev, 2007,74:321-331. (Pubitemid 46147808)
13. Viallon A, Pouzet V, Zeni F, et al. Rapid diagnosis of the type of meningitis ( bacterial or viral) by the assay of serum procalcitonin. Presse Med, 2000,29:584-588. (Pubitemid 30187069)
14. Johnson JL, Fritsche-Danielson R, Behrendt M, et al. Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability. Cardiovasc Res, 2006,71:586-595.
15. Cho HJ, Chae IH, Park KW, et al. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention. J Hum Genet, 2002,47:88-91.
16. Wilmer WA, Cosio FG. DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations. Kidney Int, 1998,53:1172-1181. (Pubitemid 28316877)
17. Pascal MM, Knott RM, Forrester JV. Glucose mediated regulation of transforming growth factor beta in human retinal endothelial cells. Biochem Soc Trans, 1996,24:228S.
18. Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol, 1997,15:519-526.
19. Blankenberg S, Rupprecht HJ, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation, 2003,107:1579-1585. (Pubitemid 36397324)